These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8338522)

  • 1. Prostate cancer: to screen or not to screen?
    Schröder FH
    BMJ; 1993 Feb; 306(6875):407-8. PubMed ID: 8338522
    [No Abstract]   [Full Text] [Related]  

  • 2. To screen or not to screen: cancer of the prostate.
    Huntington H
    Contemp Nurse; 1994 Sep; 3(3):127-30. PubMed ID: 7858385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proposal for mass screening in cancer of the prostate].
    Andreassi F; Manca P; Piras P; Bordoni P; D'Alpaos M
    Minerva Urol Nefrol; 1987; 39(4):325-8. PubMed ID: 3451370
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate cancer: enthusiasm for screening.
    Kaye KW
    Med J Aust; 1995 May; 162(10):540-1. PubMed ID: 7539884
    [No Abstract]   [Full Text] [Related]  

  • 5. Progress in the control of prostate cancer in Rhode Island, 1987-2000.
    Chiaverini L; Fulton JP; Darcy DM
    Med Health R I; 2002 Sep; 85(9):291-3. PubMed ID: 12371217
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for prostate cancer: are we ready?
    Adami HO; Baron J
    Cancer Epidemiol Biomarkers Prev; 1994; 3(3):193-5. PubMed ID: 8019365
    [No Abstract]   [Full Text] [Related]  

  • 7. The identification and screening of men at high risk for developing prostate cancer.
    Grumet SC; Bruner DW
    Urol Nurs; 2000 Feb; 20(1):15-8, 23-4, 46. PubMed ID: 11998038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is screening for prostate cancer the current gold standard?--"no".
    Kramer BS; Gohagan JK; Prorok PC
    Eur J Cancer; 1997 Mar; 33(3):348-53. PubMed ID: 9155515
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mass screening of prostate in Shiribeshi area in Hokkaido--incidence and clinical symptoms of benign prostatic hypertrophy and prostatic carcinoma].
    Umehara T; Kumamoto Y; Mikuma N; Yamaguchi Y; Tsukamoto T; Miura T; Watanabe H; Ooe H
    Hinyokika Kiyo; 1990 Apr; 36(4):415-23. PubMed ID: 1696062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer in North Carolina.
    Robertson C; Demark-Wahnefried W; Aldrich T
    N C Med J; 1992 Sep; 53(9):447-51. PubMed ID: 1407023
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer: to screen or not to screen?
    Oncology (Williston Park); 1997 Mar; 11(3):325-6, 329-30. PubMed ID: 9109125
    [No Abstract]   [Full Text] [Related]  

  • 12. [Early detection or screening in the prevention of prostate cancer?].
    Brenes Bermúdez FJ; Alcántara Montero A
    Semergen; 2017 Mar; 43(2):100-108. PubMed ID: 26960257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New proposals from the EC with regard to public health.
    Eur J Cancer Care (Engl); 2000 Dec; 9(4):179-80. PubMed ID: 11829361
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cancer of the prostate. Should men be screened, how to screen, when to screen?].
    Abbou CC; Haillot O; Ravery V
    Ann Urol (Paris); 1996; 30(6-7):283-6; discussion 286-93. PubMed ID: 9092382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to use PSA to screen for prostate cancer.
    Little B; Young M
    Int J Clin Pract; 2003; 57(1):40-2. PubMed ID: 12587941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer: who to screen, and what the results mean.
    Small EJ
    Geriatrics; 1993 Dec; 48(12):28-30, 35-8. PubMed ID: 7504646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for prostate cancer: the role of prostate-specific antigen.
    Ferrer RL
    Md Med J; 1996 Nov; 45(11):938-40. PubMed ID: 8942171
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostate carcinoma: clarification through clinical insight and molecular diagnostics.
    Meyers FJ; DeVere White RW
    West J Med; 1998 Jun; 168(6):525. PubMed ID: 9655997
    [No Abstract]   [Full Text] [Related]  

  • 19. Epidemiology of prostate cancer in two European countries: Scotland and Norway.
    Galletly C; Whyte F
    Eur J Cancer Care (Engl); 1998 Dec; 7(4):240-6. PubMed ID: 9919111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer screening. Why the controversy?
    Walther PJ
    Surg Oncol Clin N Am; 1995 Apr; 4(2):315-34. PubMed ID: 7540938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.